Since 1992, Omnicell has been creating innovative solutions to improve patient care, anywhere it is delivered. The Company is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire healthcare continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities, to the patient’s home. A lot of customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry. The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions.
Company Growth (employees)
Mountain View, US
Size (employees)
2,444 (est)
Omnicell was founded in 1992 and is headquartered in Mountain View, US

Key People/Management at Omnicell

Randall Lipps

Randall Lipps

Chairman, President, Chief Executive Officer, and Founder
J. Drew

J. Drew

President, North American Automation and Analytics
Dan Johnston

Dan Johnston

Executive Vice President and Chief Legal and Administrative Officer
Peter Kuipers

Peter Kuipers

Executive Vice President and Chief Financial Officer
Rob Seim

Rob Seim

President, Global Automation and Medication Adherence
Jorge Taborga

Jorge Taborga

Executive Vice President, Engineering
Nhat Ngo

Nhat Ngo

Executive Vice President, Strategy and Business Development

Omnicell Office Locations

Omnicell has offices in Mountain View, Milpitas, Saint Petersburg, Waukegan and in 2 other locations
Mountain View, US (HQ)
590 E Middlefield Rd
Cranberry Township, US
500 Cranberry Woods Dr
Milpitas, US
725 Sycamore Dr
Saint Petersburg, US
2003 Gandy Blvd N
Warrendale, US
400 51 Pennwood Pl
Waukegan, US
Burwood Drive
Show all (6)

Omnicell Financials and Metrics

Omnicell Financials

Omnicell's revenue was reported to be $692.6 m in FY, 2016

Revenue (Q2, 2017)

180.9 m

Gross profit (Q2, 2017)

78 m

Gross profit margin (Q2, 2017), %


Net income (Q2, 2017)

837 k

EBIT (Q2, 2017)

(2.4 m)

Market capitalization (22-Dec-2017)

1.9 b

Cash (30-Jun-2017)

26.9 m
Omnicell's current market capitalization is $1.9 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016


380.6 m440.9 m484.6 m692.6 m

Revenue growth, %


Cost of goods sold

177.2 m207 m236.6 m378.8 m

Gross profit

203.4 m233.9 m247.9 m313.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


94 m101.8 m105.1 m112.5 m116.2 m112.8 m125.2 m171 m172.9 m176.7 m150.6 m180.9 m

Cost of goods sold

42 m47.3 m49 m53 m54.5 m55.3 m61.5 m91.1 m94.9 m95.2 m86.4 m102.9 m

Gross profit

52 m54.5 m56 m59.5 m61.7 m57.5 m63.7 m79.9 m78 m81.5 m64.2 m78 m

Gross profit Margin, %

USDFY, 2013FY, 2014FY, 2015FY, 2016


104.5 m125.9 m82.2 m54.5 m

Accounts Receivable

598 k


31.5 m46.6 m69.3 m

Current Assets

233.8 m283.4 m264.1 m315.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017


116.2 m107.6 m126.4 m104.2 m139.6 m88 m57.8 m53.5 m41 m47.3 m46.3 m26.9 m


30.7 m31 m31.5 m31.8 m33.2 m46 m49.5 m71.9 m73.7 m74.1 m76.2 m81.5 m

Current Assets

247.9 m250.8 m275.9 m268.4 m296.3 m285.3 m259.9 m310.3 m311.9 m337.1 m294.4 m296 m


33.5 m35.2 m37.3 m37.7 m34.4 m34.8 m34 m42.2 m40.5 m41 m41 m40.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

24 m30.5 m30.8 m603 k

Depreciation and Amortization

18.4 m20.3 m25.6 m58.4 m

Accounts Receivable

(3.6 m)(23 m)(18 m)8 m


(5.4 m)1.4 m(10 m)(3.4 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

7.8 m6.2 m7.8 m7.3 m6.3 m8.8 m8 m(378 k)(1.2 m)2 m(10.8 m)


31.5 m31.8 m49.5 m71.9 m73.7 m74.1 m76.2 m

Accounts Payable

19 m23.2 m21.8 m26.1 m24.7 m32.1 m37.4 m36.7 m38.5 m
USDY, 2017


74 k

Financial Leverage

2 x
Show all financial metrics

Omnicell Market Value History

Omnicell Median Salaries

Source: 106 public H-1B filings from Omnicell

Omnicell's Web-traffic and Trends

Omnicell Online and Social Media Presence

Omnicell News and Updates

North America Medical Carts Market to exhibit a CAGR of nearly 11.2% during the forecast period 2017-2027

Future Market Insights has announced the addition of the “Medical Carts Market: North America Industry Analysis and Opportunity Assessment 2017-2027" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Pharmacy IT specialist Positive Solutions partners with Cambrian Alliance Group

Integrated pharmacy systems now available to Cambrian Alliance Group members at discounted rates Posted via Industry Today. Follow us on Twitter @IndustryToday

Omnicell Company Life and Culture

You may also be interested in